Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-68

Always non performing stocks are the first to go from a portfolio , next are those with a long horizon to income.... New Investors want to be part of something successful and that equates to a strong graph,, bottom left moving to top right... BOT graph looks sporadic and the only heavy declines have been a direct cause of CR's.. the last run ,,well should have been left to run..... plus now being a penny stock (under 10c) didn't help BOT cause, they were just receiving the attention they deserved from the wider market and the CR was to heavily discounted...

I have a chunk parked here,,,that has cost me opportunities elsewhere but as long as BOT bring a product to commercialisation the reward here should be substantial.....

Management effectively devalued their own work and progress,,, a commercial deal should have been a priority and seeking a market partner for an exit strategy..

Company have been taking their time and the market knows this,,,plus others are working away in the States and UK... 

You would have seen other companies now rushing to fill gaps in the MC product catalogue ,, BOT were advanced but are now part of the herd,, 

Bad timing demonstrated Managements poor read of the Market.... I have been investing for 20 years and with everything I thought i knew , I honestly thought BOT would have let that last run take them into the High 20c range possibly 30c.... plus the Market are aware that the insto will take 6 weeks to churn back the 139,000,000 shares they have,, now heading for a 4th month since the CR and the Insto has been locked in with no return,,this will reflect badly on BOT to the Insto,,especially the next time they need Money?? my take is they will ask Shareholders for the next trench as the insto will want an even greater discount on the next run...

Commercialisation is the key,,, announcing BUSINESS with partners or proposed partners or interested parties will see the SP strengthen,,